Back to Trades
Wiley Matthew T.
Chief Commercial OfficerCIK 0001759703
Total Volume
$242.4K
5 filings
Purchases
$0
0 buy txns
Sales
$242.4K
2 sell txns
Net Activity
-$242.4K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Wiley Matthew T., Chief Commercial Officer, has filed 5 SEC reports (2026), all concentrated in Definium Therapeutics, Inc. (DFTX), totaling $242.4K in disclosed volume. Weighing $0 bought versus $242.4K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Sep 29 | DFTX Definium Therapeutics, Inc. | Wiley Matthew T. | Chief Commercial Officer | Sell | $113.3K |
| Sep 14 | DFTX Definium Therapeutics, Inc. | Wiley Matthew T. | Insider | Grant | $0 |
| Aug 12 | DFTX Definium Therapeutics, Inc. | Wiley Matthew T. | Insider | Grant | $0 |
| Jun 26 | DFTX Definium Therapeutics, Inc. | Wiley Matthew T. | Insider | Sell | $129.1K |
| Jun 22 | DFTX Definium Therapeutics, Inc. | Wiley Matthew T. | Insider | Grant | $0 |
5 filings